BUZZ-Trillium Therapeutics Inc: Touches more than 2-month high
** Canadian cancer drug maker's shares up 7.6 pct at 2-month high of C$15.87 mid-morning
** U.S.-listed shares up 6.4 pct at $12.19; also touches 2 month-high of $12.38
** U.S. FDA gives company clearance to proceed with early-stage study of its drug in patients with solid tumors and mycosis fungoides, a common form of skin-related T-cell lymphoma
** Company expects to enroll patients by year-end and initial data in late 2017
** Up to Tuesday's close, Toronto stock had fallen 15 pct this year, while U.S.-listed stock had fallen 9 pct
© Thomson Reuters 2017 All rights reserved.